πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8455454

miR 204, miR 211, their anti-miRs, and therapeutic uses of same

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8455437

Method to predict and prevent oxygen-induced inflammatory tissue injury

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8454972

Method for inducing a multiclade immune response against HIV utilizing a multigene and mul

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8454965

Method for the treatment of multiple sclerosis

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8454936

Metal chelators and methods of their use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8450325

Methods for reducing the recurrence of cardiac arrhythmia

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8445658

Proteins with repetitive bacterial-Ig-like (Big) domains present in Leptospira species

THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS Β· Granted Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8445216

Antibodies and immunotoxins that target human glycoprotein NMB

The United States of America as Represented by the Secretary of Health and Human Services, National Institutes of Health Β· Granted Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8444996

Multicomponent vaccine for malaria providing long-lasting immune responses against plasmod

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8440415

BORIS isoforms and methods of detecting and treating disease

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8440411

Differential gene expression in physiological and pathological angiogenesis

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8440393

Pro-angiogenic genes in ovarian tumor endothelial cell isolates

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8440206

Methods for producing an immune response to tuberculosis

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8435979

Use of imipramine blue and analogs thereof in treating cancers

The United States of America as Represented by the Dept. of Veterans Affairs Β· Granted Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8435507

Prostate-specific antigen-derived MHC class II restricted peptides and their use in vaccin

The United States of America as Represented by the Dept. of Veterans Affairs Β· Granted Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8431690

T cell receptors and related materials and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8431134

Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathoge

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8431176

Liquid chromatographic fraction of enzymatically polymerized flavonoid as an antioxidant

The United States of America as represented by the Secretary of the Army Β· Granted Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8426575

N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and no

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8426574

Identification of astrovirus VA1 associated with gastroenteritis in humans

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8426379

POT1 alternative splicing variants

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8420664

A3 adenosine receptor allosteric modulators

THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPT. HEALTH & HUMAN SERVICES Β· Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8420620

Induced internalization of surface receptors

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8420607

Anthrax carbohydrates, synthesis and uses thereof

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted